XML 107 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investments in and Advances to Unconsolidated Joint Ventures - Narrative (Details)
$ in Millions
1 Months Ended 12 Months Ended
Aug. 01, 2022
USD ($)
property
Dec. 31, 2023
USD ($)
property
Dec. 31, 2022
USD ($)
Schedule of Equity Method Investments [Line Items]      
Difference between carrying amount and underlying equity   $ 49 $ 41
Gain (loss) on deconsolidation     $ 311
Lab      
Schedule of Equity Method Investments [Line Items]      
Property count | property   2  
Life Science Joint Venture In San Francisco, California | Lab      
Schedule of Equity Method Investments [Line Items]      
Investment ownership percentage 70.00%    
Property count | property 7    
Callan Ridge Joint Venture      
Schedule of Equity Method Investments [Line Items]      
Proceeds from nonrefundable deposit   $ 8  
Callan Ridge Joint Venture | Lab      
Schedule of Equity Method Investments [Line Items]      
Property count | property   2  
Life Science Joint Venture In San Francisco, California | Life Science Joint Venture In San Francisco, California | Lab      
Schedule of Equity Method Investments [Line Items]      
Investment ownership percentage 30.00%    
Cash proceeds $ 126    
Callan Ridge Joint Venture | Callan Ridge Joint Venture | Lab      
Schedule of Equity Method Investments [Line Items]      
Investment ownership percentage   65.00%  
Cash proceeds   $ 128  
Equity method investments   $ 110